Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial

Dendritic cells (DCs) are antigen-presenting cells that are capable of priming anti-tumor immune responses, thus serving as attractive tools to generate tumor vaccines. In this multicentric randomized open-label phase II study, we investigated the efficacy of vaccination with tumor lysate-charged au...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchroithner, Johanna, Erhart, Friedrich, Pichler, Josef, Widhalm, Georg, Preusser, Matthias, Stockhammer, Günther, Nowosielski, Martha, Iglseder, Sarah, Freyschlag, Christian F., Oberndorfer, Stefan, Bordihn, Karin, von Campe, Gord, Hoffermann, Markus, Ruckser, Reinhard, Rössler, Karl, Spiegl-Kreinecker, Sabine, Fischer, Michael B., Czech, Thomas, Visus, Carmen, Krumpl, Günther, Felzmann, Thomas, Marosi, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210090/
https://www.ncbi.nlm.nih.gov/pubmed/30301187
http://dx.doi.org/10.3390/cancers10100372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210090/
https://www.ncbi.nlm.nih.gov/pubmed/30301187
http://dx.doi.org/10.3390/cancers10100372

Ejemplares similares